- Filed
- Apr 29, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 25, 2025 | 8.02M sh |
| Long Term Debt | Q1 2025 · Mar 29, 2025 | $295.39M |
| Long Term Debt | Q1 2025 · Dec 28, 2024 | $295.06M |
| Cash And Equivalents | Q1 2025 · Mar 29, 2025 | $449.02M |
| Cash And Equivalents | Q1 2025 · Dec 28, 2024 | $505.62M |
| Current Liabilities | Q1 2025 · Mar 29, 2025 | $280.57M |
| Current Liabilities | Q1 2025 · Dec 28, 2024 | $233.72M |
| Total Liabilities | Q1 2025 · Mar 29, 2025 | $997.36M |
| Total Liabilities | Q1 2025 · Dec 28, 2024 | $931.28M |
| Current Assets | Q1 2025 · Mar 29, 2025 | $1.17B |
| Current Assets | Q1 2025 · Dec 28, 2024 | $1.13B |
| Total Assets | Q1 2025 · Mar 29, 2025 | $1.63B |
| Total Assets | Q1 2025 · Dec 28, 2024 | $1.58B |
| Shares Diluted restated | Q1 2025 · Mar 30, 2024 | 8.74M sh |
| Stock Repurchased | Q1 2025 · Mar 30, 2024 | $0 |
| Capex | Q1 2025 · Mar 30, 2024 | $5.45M |
| Operating Cash Flow | Q1 2025 · Mar 30, 2024 | −$31.14M |
| Stockholders Equity | Q1 2025 · Mar 30, 2024 | $653.22M |
| Stockholders Equity | Q1 2025 · Dec 30, 2023 | $634.29M |
| Eps Diluted | Q1 2025 · Mar 30, 2024 | $2.00 |
| Eps Basic | Q1 2025 · Mar 30, 2024 | $2.02 |
| Sga Expense | Q1 2025 · Mar 30, 2024 | $91.25M |
| Net Income | Q1 2025 · Mar 30, 2024 | $17.49M |
| Operating Income | Q1 2025 · Mar 30, 2024 | $27.67M |
| Gross Profit | Q1 2025 · Mar 30, 2024 | $127.68M |
| Cost Of Revenue | Q1 2025 · Mar 30, 2024 | $598.56M |
| Revenue | Q1 2025 · Mar 30, 2024 | $726.24M |